Within AD and control cohorts, plasma levels of p‐tau217 correlate with tau positron emission tomography (PET) pathology11 and tangle load at autopsy12 and are elevated in disorders with tangles but without amyloid plaques,13 supporting its reflection of tau phosphorylation and pathology. This evidence concerns the gene MAPT and Alzheimer disease.